Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2005
08/18/2005US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation
08/18/2005US20050182019 Phosphonate compounds
08/18/2005US20050181995 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
08/18/2005US20050181507 Gene delivery vectors with cell type specificity for mesenchymal stem cells
08/18/2005US20050181414 Peptides associated with serine protease active site for use in identification of modulators for treatment of cell proliferative disorders
08/18/2005US20050181368 Protein for use in hypoxia related conditions
08/18/2005US20050181066 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
08/18/2005US20050181038 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
08/18/2005US20050180991 Tricholoma matsutake of the FERM BP-7304 strain, and any of mycelia, broths, or fruit bodies (including spores) thereof, as they are, dried products thereof, or extracts thereof
08/18/2005US20050180963 Probiotic propionibacterium
08/18/2005US20050180959 Kinases involved in the regulation of energy homeostasis
08/18/2005DE102004004974A1 Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen Thieno-imino acid derivatives as inhibitors of matrix metalloproteinases
08/18/2005DE10134196B4 Pharmazeutische Zusammensetzung zur Hemmung der unkontrollierten Vermehrung und/oder Induzierung der Apoptose von Zellen A pharmaceutical composition for inhibiting uncontrolled proliferation and / or inducing apoptosis of cells
08/18/2005CA2556181A1 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent
08/18/2005CA2555632A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
08/18/2005CA2555316A1 Combined pharmaceutical composition
08/18/2005CA2555262A1 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
08/18/2005CA2554683A1 Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers
08/18/2005CA2553928A1 Susceptibility gene for myocardial infarction, stroke, and paod; methods of treatment
08/18/2005CA2497216A1 Local vascular delivery of cladribine in combination with rapamycin to prevent restenosis following vascular injury
08/17/2005EP1564219A1 N-terminally monopegylated polypeptides and process for their preparation
08/17/2005EP1564213A1 Imidazole derivative, process for producing the same, and use
08/17/2005EP1564202A1 Novel process for synthesizing and a novel crystal form of agomelatin as well as pharmaceutical preparations containing these
08/17/2005EP1563846A1 Endogenous repair factor production promoters
08/17/2005EP1563843A1 Botulinum toxins for treating various disorders and associated pain
08/17/2005EP1563836A1 Drug for inhibiting production of matrix metalloprotease-9
08/17/2005EP1562939A1 Carboxamides
08/17/2005EP1562938A1 Heteroaryl-pyrimidine derivatives as jak inhibitors
08/17/2005EP1562937A2 N-substituted piperidine derivatives as serotonin receptor agents
08/17/2005EP1562935A1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
08/17/2005EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
08/17/2005EP1562920A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
08/17/2005EP1562629A1 Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
08/17/2005EP1562590A2 Compounds, methods and devices for inhibiting neoproliferative changes in blood vessel walls
08/17/2005EP1562579A1 Therapeutic delivery of carbon monoxide
08/17/2005EP1562578A1 Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
08/17/2005EP1562573A1 Pharmaceutical pellets comprising tamsulosin and a process for making the same
08/17/2005EP1562572A2 Pharmaceutical solutions of modafinil compounds
08/17/2005EP1463725B1 Process and intermediates for pyridazinone antidiabetic agents
08/17/2005EP1429617A4 Methods for sterilizing preparations of digestive enzymes
08/17/2005EP1411895B1 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine
08/17/2005EP1354597B1 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
08/17/2005EP1282639B1 Polyamide nucleic acid derivatives, agents and methods for producing the same
08/17/2005EP1248651B1 Product comprising a heterotrimeric g protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
08/17/2005EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS
08/17/2005EP1144385B1 Benzoheterocycles and their use as mek inhibitors
08/17/2005EP1087943B1 Therapeutic biaryl derivatives
08/17/2005EP1087775B1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
08/17/2005EP1073723B1 Ste20-related protein kinases
08/17/2005EP1023445B1 Cadherin derived growth factor and the application thereof
08/17/2005EP1023067B9 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/17/2005EP0991638B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS
08/17/2005EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity
08/17/2005EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
08/17/2005EP0835128B1 Use of il-11 to treat inflammation
08/17/2005EP0732930B1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
08/17/2005CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof
08/17/2005CN1656099A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
08/17/2005CN1656097A Xanthine phosphodiesterase V inhibitor polymorphs
08/17/2005CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders
08/17/2005CN1656093A 3-substituted quinuclidines and their use
08/17/2005CN1656091A Tetrahydropyran derivatives
08/17/2005CN1656088A Substituted chroman derivatives having cytochrome P450RAI inhibitory activity
08/17/2005CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient
08/17/2005CN1656084A Hydroxymorpholinone derivative and medicinal use thereof
08/17/2005CN1656081A 4-anilino quinazoline derivatives as antiproliferative agents
08/17/2005CN1656078A Aminoindazole derivatives as protein kinase inhibitor
08/17/2005CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
08/17/2005CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
08/17/2005CN1656070A Melanocortin receptor ligands
08/17/2005CN1656069A 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
08/17/2005CN1656067A New salts
08/17/2005CN1656066A Pharmaceutical combination
08/17/2005CN1656058A Amide derivatives as inhibitors of the enzymatic activity of renin
08/17/2005CN1655848A Use of new etonogestrel esters
08/17/2005CN1655845A Use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
08/17/2005CN1655833A Medical devices containing rapamycin analogs
08/17/2005CN1655822A Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
08/17/2005CN1655820A Pharmaceutical combination of PDE5 inhibitors with ace inhibitors
08/17/2005CN1655819A Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
08/17/2005CN1655816A Drugs for treating vascular diseases
08/17/2005CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
08/17/2005CN1655809A Compositions and methods for treating and preventing necrosis
08/17/2005CN1655806A Treatment of diseases involving defective gap junctional communication
08/17/2005CN1655804A Method and composition for treating cardiovascular diseases by employing neuroregulation protein
08/17/2005CN1655792A Combination product of a 1, 4-benzothiepine 1, 1-dioxide compound with at least one other active ingredient and the use of the product
08/17/2005CN1655790A Medicinal composition
08/17/2005CN1655786A Combination of a DPP IV inhibitor and a cardiovascular compound
08/17/2005CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
08/17/2005CN1655775A Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
08/17/2005CN1655761A Modified release pharmaceutical formulation
08/17/2005CN1655760A Immediate release pharmaceutical formulation
08/17/2005CN1655675A Combination therapy using trefoil peptides
08/17/2005CN1654663A Recombinant human VEGF and bFGF eukaryon expression vector, fused protein and applications thereof
08/17/2005CN1654652A Amphioxus dimethyl arginine hydrolase AmphiDDAH gene and its application
08/17/2005CN1654461A Process for preparing bis-phenyl fluorozine and its use as medicine in treatment of cardiovascular and cerebrovascular diseases
08/17/2005CN1654064A Chinese medicinal composition for treating respiratory illness and digestive illness
08/17/2005CN1654062A Freeze dried powder injection for treating thromboangitis obliterans and its preparing process
1 ... 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 ... 1595